The Pipeline Center

Filter Your Results

 

News

 

Pride in Progress

In the late 1960s, cigarette manufacturer Philip Morris came out with its Virginia Slims brand, which appeared in ad…

Allen C. Ho, MD, and Robert L. Avery, MD

Ocular Gene Therapy Trials Advance

“We used to think that our fate was in our stars, but now we know that, in large measure, our fate is in our g…

Aron Shapiro

Reversing Retinal Ischemia

Decreased blood flow to the retina is the underlying pathophysiology in a number of major retinal diseases, includin…

Logan Christensen, MD, and Jeffrey L. Olson, MD

Drug Delivery to the Posterior Segment

At a Glance • Intravitreal injection is the current drug delivery method of choice. • Topical drug deliv…

Daniel D. Esmaili, MD; and David S. Boyer, MD

Personalized Medicine in Ocular Oncology

At a Glance • Studies have found selective intra-arterial combination therapy with carboplatin, melphalan, and…

Victor M. Villegas, MD; Aaron S. Gold, OD; Andrea Wildner, CRA; Jennifer Thomson, CRA; Fiona J. Ehlies, BSc, CDOS; and Timothy G. Murray, MD, MBA, FACS

A Dual-Mechanism Drug for Vitreoretinal Diseases

At a Glance • Integrins are cell surface receptors involved in angiogenesis and inflammation. • Although…

Baruch D. Kuppermann, MD, PhD

The Future of Stem Cell Therapy in Retina

At a Glance • The eye is especially well suited for stem cell therapy. • There are two approaches to s…

Aron Shapiro

Role of Mitochondrial Dysfunction in Dry Age-Related Macular…

At a Glance • Mitochondrial dysfunction induced by environmental toxicants may be an important risk factor i…

Scott W. Cousins, MD

 

This Month's Supplements

 
 

Contact Info

Bryn Mawr Communications LLC
1008 Upper Gulph Road, Suite 200
Wayne, PA 19087

Phone: 484-581-1800
Fax: 484-581-1818

Karen Roman
Editor-in-Chief
484-581-1827
kroman@bmctoday.com

Janet Burk
Publisher
214-394-3551
jburk@bmctoday.com

About Retina Today

Retina Today is a publication that delivers the latest research and clinical developments from areas such as medical retina, retinal surgery, vitreous, diabetes, retinal imaging, posterior segment oncology and ocular trauma. Each issue provides insight from well-respected specialists on cutting-edge therapies and surgical techniques that are currently in use and on the horizon.